OR WAIT null SECS
October 02, 2021
Large-scale single-use bioreactors prove successful as limits are tested.
October 01, 2021
SUB bioreactor performance has had seen its limits and successes.
Early control architecture decisions can impact a facility’s long-term growth, flexibility, and efficiency.
September 02, 2021
Advancements in bioprocessing technologies test microbial fermentation adaptability.
August 25, 2021
AGC Biologics has broken ground on a new multipurpose facility in Copenhagen, Denmark, that will increase capacity.
Lonza plans to establish drug product manufacturing capabilities at is site in Guangzhou, China, to produce clinical trial and commercial supply in the country.
August 13, 2021
Rentschler Biopharma has broken ground nearby its Milford, Mass., site where it will build its new multi-product manufacturing facility for commercial production of complex molecules.
August 01, 2021
Through the adoption of single-use technology, drug manufacturers have been able to adapt to the challenges posed by the COVID-19 pandemic.
July 16, 2021
The US federal government awarded new funding to the National Institute for Innovation in Manufacturing Biopharmaceuticals, including funding under the American Rescue Plan that will be used to advance vaccine manufacturing.
July 13, 2021
GEA’s plug-and-produce skids are designed for multi-product pharmaceutical and biopharmaceutical separation.